Drugs / NVP-1203-R2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04181437 | May 2020 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1203-R2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04181437 ↗ |
| Route | Oral | “1 tablet, oral dosing” NCT04181437 ↗ |